{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:51:03Z","timestamp":1775872263561,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,11]]},"DOI":"10.7759\/cureus.103417","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:04:35Z","timestamp":1770818675000},"source":"Crossref","is-referenced-by-count":1,"title":["Rituximab-Associated Posterior Reversible Encephalopathy Syndrome in Severe Hydralazine-Induced Antineutrophil Cytoplasmic Antibody Vasculitis: An Unexpected Complication"],"prefix":"10.7759","author":[{"given":"Faiza","family":"Javed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Barbeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozair","family":"Ziauddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey J","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et al.. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996, 334:494-500.","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.01.003","article-title":"Reversible posterior leukoencephalopathy in connective tissue diseases","volume":"35","author":"Min L","year":"2006","unstructured":"Min L, Zwerling J, Ocava LC, Chen IH, Putterman C. Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum. 2006, 35:388-95. 10.1016\/j.semarthrit.2006.01.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2476-3","article-title":"Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature","volume":"32","author":"Dhillon A","year":"2012","unstructured":"Dhillon A, Velazquez C, Siva C. Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature. Rheumatol Int. 2012, 32:3707-13. 10.1007\/s00296-012-2476-3","journal-title":"Rheumatol Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000444250","article-title":"Acute respiratory distress syndrome and posterior reversible encephalopathy syndrome following rituximab therapy","volume":"6","author":"Wardrope KE","year":"2016","unstructured":"Wardrope KE, Manson L, Metcalfe W, Sullivan ED. Acute respiratory distress syndrome and posterior reversible encephalopathy syndrome following rituximab therapy. Case Rep Nephrol Dial. 2016, 6:32-9. 10.1159\/000444250","journal-title":"Case Rep Nephrol Dial"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.5.534","article-title":"Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis","volume":"60","author":"Primavera A","year":"2001","unstructured":"Primavera A, Audenino D, Mavilio N, Cocito L. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis. 2001, 60:534-7. 10.1136\/ard.60.5.534","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2151-9","article-title":"Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review","volume":"32","author":"Camara-Lemarroy CR","year":"2013","unstructured":"Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodr\u00edguez-Guti\u00e9rrez R, Galarza-Delgado DA. Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol. 2013, 32:409-15. 10.1007\/s10067-012-2151-9","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00232-7","article-title":"Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes","volume":"24","author":"Fugate JE","year":"2025","unstructured":"Fugate JE, Hawkes MA, Rabinstein AA. Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes. Lancet Neurol. 2025, 24:789-800. 10.1016\/S1474-4422(25)00232-7","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i21.6130","article-title":"Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: a case report","volume":"9","author":"Kim Y","year":"2021","unstructured":"Kim Y, Kwak J, Jung S, et al.. Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: a case report. World J Clin Cases. 2021, 9:6130-7. 10.12998\/wjcc.v9.i21.6130","journal-title":"World J Clin Cases"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032178","article-title":"A case report of posterior reversible encephalopathy syndrome caused by ANCA-associated vasculitis case report and retrospective analysis","volume":"101","author":"Dong L","year":"2022","unstructured":"Dong L, Wang L, Jiang C, et al.. A case report of posterior reversible encephalopathy syndrome caused by ANCA-associated vasculitis case report and retrospective analysis. Medicine (Baltimore). 2022, 101:e32178. 10.1097\/MD.0000000000032178","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7520-21","article-title":"Posterior reversible encephalopathy syndrome: a review of the literature","volume":"61","author":"Ando Y","year":"2022","unstructured":"Ando Y, Ono Y, Sano A, Fujita N, Ono S. Posterior reversible encephalopathy syndrome: a review of the literature. Intern Med. 2022, 61:135-41. 10.2169\/internalmedicine.7520-21","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456783-rituximab-associated-posterior-reversible-encephalopathy-syndrome-in-severe-hydralazine-induced-antineutrophil-cytoplasmic-antibody-vasculitis-an-unexpected-complication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:04:36Z","timestamp":1770818676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456783-rituximab-associated-posterior-reversible-encephalopathy-syndrome-in-severe-hydralazine-induced-antineutrophil-cytoplasmic-antibody-vasculitis-an-unexpected-complication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.103417","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,11]]}}}